High circulating CD39+ regulatory T cells predict poor survival for sepsis patients
Author(s) -
Huihuang Huang,
Ruonan Xu,
Fang Lin,
Chunmei Bao,
Siyu Wang,
Chengcheng Ji,
Ke Li,
Lei Jin,
Jingsong Mu,
Yonggang Wang,
Lei Li,
Lijian Sun,
Biao Xu,
Zheng Zhang,
FuSheng Wang
Publication year - 2014
Publication title -
international journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.278
H-Index - 89
eISSN - 1878-3511
pISSN - 1201-9712
DOI - 10.1016/j.ijid.2014.11.006
Subject(s) - sepsis , immunosuppression , medicine , receiver operating characteristic , immune system , immunology , gastroenterology , systemic inflammatory response syndrome , pathogenesis , survival analysis
Sepsis encompasses two phases, the 'hyper'-reactive phase and the 'hypo'-reactive phase. The initial inflammatory stage is quickly counterbalanced by an anti-inflammatory response, which compromises the immune system, leading to immune suppression. Regulatory T cells (Tregs) have been implicated in the pathogenesis of sepsis by inducing immunosuppression; however, the role of CD39(+) Tregs in the process of sepsis is uncertain. This study investigated the dynamic levels of CD39(+) Tregs and their phenotypic change in sepsis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom